1998
DOI: 10.1007/bf03401747
|View full text |Cite
|
Sign up to set email alerts
|

Kaposi’s Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor Confers Resistance to the Antiproliferative Effect of Interferon-α

Abstract: These studies revealed that vIRF functions to inhibit interferon-mediated growth control of a human B lymphocyte cell line by targeting IRF-1 transactivation of interferon-inducible genes. Since KSHV is a B lymphotropic herpesvirus associated with two forms of B lymphocyte neoplasms, these effects of vIRF likely contribute to B cell oncogenesis associated with KSHV infection.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
30
0
1

Year Published

2002
2002
2007
2007

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(32 citation statements)
references
References 57 publications
1
30
0
1
Order By: Relevance
“…Human B lymphocytes expressing vIRF1 are resistant to the antiproliferative effects of IFN-␣, and vIRF1 expression inhibits p53-induced apoptosis (12,33,41). MCF-7 cells expressing vIRF1 are also resistant to IFN/RA-induced cell death, possibly through interactions between vIRF1 and GRIM19 (Fig.…”
Section: Discussionmentioning
confidence: 98%
“…Human B lymphocytes expressing vIRF1 are resistant to the antiproliferative effects of IFN-␣, and vIRF1 expression inhibits p53-induced apoptosis (12,33,41). MCF-7 cells expressing vIRF1 are also resistant to IFN/RA-induced cell death, possibly through interactions between vIRF1 and GRIM19 (Fig.…”
Section: Discussionmentioning
confidence: 98%
“…As described above, KSHV carries an additional battery of vIRF genes, vIRF1 to -4 (6, 18, 34). These vIRFs have been shown to primarily attack the IFN-␣/␤ signaling pathway (3,14,16,41). Thus, KSHV may utilize K3, K5, and vIRFs to comprehensively suppress host IFN-mediated antiviral activity, which ultimately creates a favorable milieu for the establishment and/or maintenance of persistent viral infection.…”
Section: Discussionmentioning
confidence: 99%
“…They consist of a conserved N-terminal DNA-binding domain and a C-terminal regulatory domain. The DNA-binding domain is also partially conserved in vIRF-1, although the protein appears to inhibit interferon-induced transcription in reporter transfection studies by mechanisms other than binding directly to DNA (Gao et al, 1997;Li et al, 1998;Zimring et al, 1998;Flowers et al, 1998;Burysek et al, 1999a). These mechanisms involve binding to some of the cellular IRFs and to coadaptors that link transcription factors to the RNA polymerase holoenzyme (Jayachandra et al, 1999;Burysek et al, 1999a;Seo et al, 2000;Li et al, 2000;Lin et al, 2001).…”
Section: Introductionmentioning
confidence: 99%
“…The gene is assigned to the early kinetic class since its expression is resistant to inhibition of DNA replication (Wang et al, 2001). The mRNA is 1?5 kb in size Sarid et al, 1998) , 1997;Li et al, 1998;Zimring et al, 1998;Flowers et al, 1998;Burysek et al, 1999a). These mechanisms involve binding to some of the cellular IRFs and to coadaptors that link transcription factors to the RNA polymerase holoenzyme (Jayachandra et al, 1999;Burysek et al, 1999a;Seo et al, 2000;Li et al, 2000; Lin et al, 2001).…”
mentioning
confidence: 99%